Prof. Elias Mossialos

Brian Abel-Smith Professor of Health Policy and Director of LSE Health

ELIAS A. MOSSIALOS, M.D., Ph.D., FFPH, FRCP (London &Edin), is Brian Abel-Smith professor of health policy, and director of LSE Health at the London School of Economics and Political Science. His particular research focus is European and comparative health policy, addressing questions related to financing health care, pharmaceutical policies, private health insurance and the impact of EU law on health care systems. In 1998, he co-founded the European Observatory on Health Systems and Policies, a major health policy research and knowledge transfer programme. Mossialos is an honorary professor at the University of Copenhagen, Imperial College, the London School of Hygiene & Tropical Medicine, and L’Ecole des Hautes Etudes en Santé Publique in France. He edits the Cambridge University Press Health Economics, Policy and Management book series and is co-editor in chief of Health Economics, Policy and Law, a journal published by Cambridge University Press, and editor in chief of the Health Systems in Transition reports published by WHO. He is also a member of the Health, Demographic Change and Well-being Advisory Group for the Horizon 2020 Research Programme of the European Commission. He was the 2002 and 2007 recipient of the Baxter Award from the European Health Management Association for the best publication in health policy and management in Europe. In 2010 he was awarded the Andrija Stampar medal by the Association of Schools of Public Health in Europe for contributions to European public health. LSE Health was honored with the prestigious Queen’s Anniversary Prize for Higher Education in 2009. Mossialos has been an active participant in policy debates, advising the World Health Organization, the European Parliament, the European Commission, the World Bank, the UK Office of Fair Trading, Ministries of Health and Social Affairs in Belgium, Brazil, China, Finland, Ireland, Russia, Slovenia, South Africa, Spain and Sweden, and health insurance funds in Austria, Croatia, France, Hungary and South Korea. He has been a member of the management board of the European Medicines Agency (2000-03).